mesalamine has been researched along with Bright Disease in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Velciov, S | 1 |
| Gluhovschi, G | 1 |
| Sporea, I | 1 |
| Trandafirescu, V | 1 |
| Petrica, L | 1 |
| Bozdog, G | 1 |
| Gluhovschi, C | 1 |
| Bob, F | 1 |
| Gădălean, F | 1 |
| Buzaş, R | 1 |
| Bobu, M | 1 |
| Voicu, L | 1 |
1 other study available for mesalamine and Bright Disease
| Article | Year |
|---|---|
Asymptomatic urinary anomalies, hematuria and proteinuria, in patients with inflammatory bowel disease. Preliminary study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Diagnosis, Diffe | 2011 |